Citation Impact
Citing Papers
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
2002
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2016 Standout
Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective
2002
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials
2002
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
2008 Standout
Classification of Surgical Complications
2004 Standout
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma
2003
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?
1998
Management of Hepatocellular Carcinoma *
2005 Standout
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
1997
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Treatment of hepatocellular carcinoma in patients with cirrhosis
1997
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
2006
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
The place of downstaging for hepatocellular carcinoma
2010
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis
1997
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
Postoperative pancreatic fistula: An international study group (ISGPF) definition
2005 Standout
Quality of Complication Reporting in the Surgical Literature
2002
Hepatocellular Carcinoma
2011
Treatment of Stage IVA Hepatocellular Carcinoma
2008
Hepatocellular Carcinoma
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Simplified Staging for Hepatocellular Carcinoma
2002
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
2011
Simplified Staging for Hepatocellular Carcinoma
2002
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
2009
Works of William‐Lin Ho being referenced
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
1995
Hepatic resection for bilobar multicentric hepatocellular carcinoma: Is it justified?
1998
Liver resection for hepatocellular carcinoma in octogenarians
1999
Hepatic resection for bilobar multicentric hepatocellular carcinoma: Is it justified?
1998